We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+3.89%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$16.7B
AUM Growth
+$10.2M
(+0.06%)
Cap. Flow
-$510M
Cap. Flow
% of AUM
-3.05%
Top 10 Holdings %
Top 10 Hldgs %
20.67%
Holding
1,686
New
28
Increased
245
Reduced
1,348
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$22.8M |
| 2 |
Cardinal Health
CAH
|
+$16.4M |
| 3 |
Hormel Foods
HRL
|
+$16.3M |
| 4 |
Pentair
PNR
|
+$15.9M |
| 5 |
AbbVie
ABBV
|
+$15.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$70.1M |
| 2 |
Microsoft
MSFT
|
+$56.8M |
| 3 |
Amazon
AMZN
|
+$50.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$24.3M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.86% |
| 2 | Financials | 13.33% |
| 3 | Healthcare | 11.75% |
| 4 | Industrials | 10.99% |
| 5 | Consumer Staples | 10.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
1301
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $270K | ﹤0.01% |
20,835
-2,759
| -12% | -$35.4K |
|
|
PETQ
1302
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $270K | ﹤0.01% |
8,204
-746
| -8% | -$22K |
|
1303
Huntsman Corp
HUN
$2.24B
| $269K | ﹤0.01% |
13,147
+171
| +1% | +$3.59K |
|
1304
Evertec
EVTC
$1.83B
| $268K | ﹤0.01% |
8,182
-174
| -2% | -$5.12K |
|
1305
Ormat Technologies
ORA
$6.11B
| $267K | ﹤0.01% |
4,218
-112
| -3% | -$6.67K |
|
|
CUB
1306
DELISTED
Cubic Corporation
CUB
| $267K | ﹤0.01% |
4,139
-86
| -2% | -$5.05K |
|
|
AKRX
1307
DELISTED
Akorn Inc
AKRX
| $266K | ﹤0.01% |
51,622
-7,653
| -13% | -$29.4K |
|
|
CADE
1308
DELISTED
Cadence Bancorporation
CADE
| $265K | ﹤0.01% |
12,746
-333
| -3% | -$6.85K |
|
1309
Ryder
R
$10.4B
| $264K | ﹤0.01% |
4,534
-172
| -4% | -$10.2K |
|
1310
Cytokinetics
CYTK
$11B
| $263K | ﹤0.01% |
23,393
-1,769
| -7% | -$17.1K |
|
1311
Meritage Homes
MTH
$4.87B
| $262K | ﹤0.01% |
10,188
-230
| -2% | -$5.81K |
|
1312
Progress Software
PRGS
$1.55B
| $262K | ﹤0.01% |
6,017
-150
| -2% | -$6.5K |
|
1313
Werner Enterprises
WERN
$2.54B
| $260K | ﹤0.01% |
8,379
-303
| -3% | -$9.77K |
|
1314
Zillow
Z
$7.04B
| $260K | ﹤0.01% |
+5,607
| New | +$223K |
|
|
ROIC
1315
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $260K | ﹤0.01% |
15,186
-313
| -2% | -$5.42K |
|
1316
Allegiant Air
ALGT
$2.64B
| $258K | ﹤0.01% |
1,796
-35
| -2% | -$4.91K |
|
1317
Rocket Pharmaceuticals
RCKT
$348M
| $258K | ﹤0.01% |
17,185
-133
| -0.8% | -$2.32K |
|
1318
Taylor Morrison
TMHC
$6.67B
| $258K | ﹤0.01% |
12,306
-352
| -3% | -$7K |
|
|
LTXB
1319
DELISTED
LegacyTexas Financial Group Inc
LTXB
| $258K | ﹤0.01% |
6,345
-129
| -2% | -$5.06K |
|
1320
Rhythm Pharmaceuticals
RYTM
$7B
| $257K | ﹤0.01% |
11,661
-1,682
| -13% | -$42.5K |
|
1321
Graham Holdings Company
GHC
$4.97B
| $255K | ﹤0.01% |
369
-13
| -3% | -$9.08K |
|
1322
NeoGenomics
NEO
$1.81B
| $255K | ﹤0.01% |
11,631
-14
| -0.1% | -$307 |
|
|
ARGO
1323
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $255K | ﹤0.01% |
3,438
-88
| -2% | -$6.45K |
|
1324
OSI Systems
OSIS
$3.57B
| $254K | ﹤0.01% |
2,259
-53
| -2% | -$5.34K |
|
1325
Quanterix
QTRX
$173M
| $253K | ﹤0.01% |
7,502
-967
| -11% | -$25K |
|
Similar funds
ProShare Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, ProShare Advisors held 1,686 positions worth $16.7B, up 0.06% from $16.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
ProShare Advisors withdrew a net $510M in Q2 2019, closing 61 positions and reducing 1,348 holdings. Its most notable exit was Bemis, an estimated $12.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, ProShare Advisors opened a new position in Dow Inc worth $13.3M.
- ProShare Advisors's largest Q2 2019 buy was Dow Inc: 269,509 shares worth $13.3M.
- ProShare Advisors added most to Walgreens Boots Alliance in Q2 2019, an estimated $22.8M increase.
- ProShare Advisors's biggest Q2 2019 reduction was Apple, cutting an estimated $70.1M.
- ProShare Advisors fully exited Bemis in Q2 2019, selling an estimated $12.7M.
- ProShare Advisors's ten largest holdings make up 21% of its $16.7B portfolio in Q2 2019.
- ProShare Advisors opened 28 new positions and closed 61 in Q2 2019.
- ProShare Advisors's portfolio value rose 0.06% quarter-over-quarter to $16.7B.
Based on ProShare Advisors's 13F filing for Q2 2019, filed 13 Aug 2019.